6 studies found for:    ONO-2506
Show Display Options
Rank Status Study
1 Completed Study of ONO-2506 in Patients With Acute Ischemic Stroke
Condition: Stroke
Intervention: Drug: ONO-2506
2 Completed Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: ONO-2506PO
3 Completed A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: ONO-2506PO
4 Completed Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan
Condition: Parkinson's Disease
Intervention: Drug: ONO-2506PO
5 Completed Effects of ONO-2506PO in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: ONO-2506PO
6 Terminated A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke
Condition: Cerebrovascular Accident
Intervention: Drug: ONO-2506

Indicates status has not been verified in more than two years